Cargando…
FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge
Feline immunodeficiency virus (FIV) is the feline analogue to human immunodeficiency virus (HIV) and utilizes parallel modes of receptor-mediated entry. The FIV surface glycoprotein (SU) is an important target for induction of neutralizing antibodies, and autoantibodies to the FIV binding receptor (...
Autores principales: | Miller, Craig, Emanuelli, Mauren, Fink, Elizabeth, Musselman, Esther, Mackie, Ryan, Troyer, Ryan, Elder, John, VandeWoude, Sue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928050/ https://www.ncbi.nlm.nih.gov/pubmed/29736270 http://dx.doi.org/10.1038/s41541-018-0051-y |
Ejemplares similares
-
Applications of the FIV Model to Study HIV Pathogenesis
por: Miller, Craig, et al.
Publicado: (2018) -
Immunopathologic Effects of Prednisolone and Cyclosporine A on Feline Immunodeficiency Virus Replication and Persistence
por: Miller, Craig, et al.
Publicado: (2019) -
Pathogenesis of oral FIV infection
por: Miller, Craig, et al.
Publicado: (2017) -
FIV cross-species transmission: An evolutionary prospective
por: Troyer, Jennifer L., et al.
Publicado: (2008) -
Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax(®) FIV)
por: Westman, Mark, et al.
Publicado: (2021)